カテゴリー： MarketsandMarkets, 世界, 医療/バイオ

世界の合成生物学市場（～2027）：ツール別（オリゴヌクレオチド、酵素、合成細胞）、技術別、用途別

◆英語タイトル：Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Genome Engineering, Bioinformatics), Applications (Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental)- Global Forecast to 2027

MarketsandMarketsが発行した調査報告書（BT2910-23）◆商品コード：BT2910-23
◆発行会社（リサーチ会社）：MarketsandMarkets
◆発行日：2023年2月6日
◆ページ数：441
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後24時間以内）
◆調査対象地域：グローバル
◆産業分野：バイオ
◆販売価格オプション（消費税別）
Single User（1名様閲覧）USD4,950 ⇒換算￥742,500見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算￥997,500見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算￥1,222,500見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

マーケット＆マーケット社の本調査資料では、世界の合成生物学市場規模が2022年に357億ドルとなり、2027年までに114億ドルに達すると予測しています。さらに、予測期間中に年平均25.6%で拡大すると展望しています。本書では、合成生物学の世界市場について詳しく分析し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、ツール別（オリゴヌクレオチド・合成、酵素、クローニング技術キット、合成細胞、その他）分析、技術別（遺伝子合成、ゲノムエンジニアリング、シーケンス、バイオインフォマティクス、その他）分析、用途別（医療、工業、食品・農業、環境）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況、企業情報などの項目を整理しています。また、Thermo Fisher Scientific (US)、Merck KGaA (Germany)、Agilent Technologies (US)、Novozymes (Denmark)、Ginkgo Bioworks (US)などの企業情報が含まれています。
・イントロダクション
・調査手法
・エグゼクティブサマリー
・プレミアムインサイト
・市場概要
・世界の合成生物学市場規模：ツール別
- オリゴヌクレオチド・合成の市場規模
- 酵素の市場規模
- クローニング技術キットの市場規模
- 合成細胞の市場規模
- その他の市場規模
・世界の合成生物学市場規模：技術別
- 遺伝子合成の市場規模
- ゲノムエンジニアリングの市場規模
- シーケンスの市場規模
- バイオインフォマティクスの市場規模
- その他の市場規模
・世界の合成生物学市場規模：用途別
- 医療における市場規模
- 工業における市場規模
- 食品・農業における市場規模
- 環境における市場規模
・世界の合成生物学市場規模：地域別
- 北米の合成生物学市場規模
- ヨーロッパの合成生物学市場規模
- アジア太平洋の合成生物学市場規模
- 中南米の合成生物学市場規模
- 中東・アフリカの合成生物学市場規模
・競争状況
・企業情報

“The global synthetic biology market size is projected to reach USD 35.7 billion by 2027 from USD 11.4 billion in 2022, at a CAGR of 25.6% during the forecast period. ”
Factors such as increasing investment in synthetic biology research, declining cost of DNA sequencing, increasing adoption of synthetic biology across various industries are driving the market growth at faster pace.

“The oligonucleotides and synthetic DNA segment is likely to grow at highest CAGR during the forecast period of 2022-2027.”
On the basis of tools, the synthetic biology market is segmented into oligonucleotides & synthetic DNA, enzymes, cloning technology kits, synthetic cells, chassis organisms, and xeno-nucleic acids. The oligonucleotides and synthetic DNA segment is projected to grow at highest CAGR during the forecast period. The growth is attributed to increased demand for synthetic DNA, synthetic RNA, and synthetic genes across various industries. Furthermore, launch of novel products in the market is further likely to have positive impact on the segmental growth.

“The gene synthesis segment held dominant share in 2021.”
Based on technology, the market is segmented into gene synthesis, genome engineering, sequencing, bioinformatics, cloning, site-directed mutagenesis, measurement and modeling, microfluidics, nanotechnology. The genome engineering segment is expected to grow at faster pace during the the forecast period due to factors such as the use of these techniques in therapeutics development, advancement in CRISPR technologies is increasing adoption.

“in 2021, medical applications segment held dominant share.”
Based on application, the synthetic biology market is segmented into medical applications, industrial applications, food & agriculture, and environmental applications. The medical applications segment held domiant share in synthetic biology market . Adoption of synthetic biology in research and drug discovery & development is one of the major factor anticipated to project the market growth.

“Asia Pacific region is likely to grow at faster pace.”
The synthetic biology market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2021, North America accounted for the dominant share in synthetic biology market. The dominance of the region is attributable to various factors such as presence of dominant and key market players in the region coupled augmented use of synthetic biology in various application. Asia Pacific region is likely to grow at faster pace owing to various factors such as rise in demand for synthetic cells across the region, increased research and development funding and emergence of new market players in the synthetic biology market.

The primary interviews conducted for this report can be categorized as follows:
• By Respondent: Supply Side- 60%, and Demand Side – 40%
• By Designation (Supply Side): Managers – 45%, CXOs & Directors – 25%, Executives- 15%, Other -15.0%
• By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%

Lists of Companies Profiled in the Report:
• Thermo Fisher Scientific (US)
• Merck KGaA (Germany)
• Agilent Technologies (US)
• Novozymes (Denmark)
• Ginkgo Bioworks (US)
• Amyris (US)
• Precigen (US)
• GenScript Biotech Corporation (China)
• Twist Bioscience (US)
• Synthetic Genomics (US)
• Codexis (US)
• Synthego (US)
• Creative Enzymes (US)
• Eurofins Scientific (Luxembourg)
• Cyrus Biotechnology (US)
• ATUM (US)
• TeselaGen (US)
• Arzeda (US)
• Integrated DNA Technologies (US)
• New England Biolabs (US)
• Elevate Bio (US)
• ZENFOLD (Iosynth) (India)
• Synbio Technologies (US)
• Inscripta, Inc. (US)
• CRISPR Therapeutics (Switzerland).

Research Coverage:
This report provides a detailed picture of the synthetic biology market. It aims at estimating the size and future growth potential of the market across different segments, such as tool, technology, application, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall synthetic biology market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market’s pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.

❖ レポートの目次 ❖

1 INTRODUCTION 56
1.1 STUDY OBJECTIVES 56
1.2 MARKET DEFINITION AND SCOPE 56
1.2.1 INCLUSIONS AND EXCLUSIONS 56
1.2.2 MARKETS COVERED 57
1.2.3 YEARS CONSIDERED 58
1.3 CURRENCY 58
1.4 STAKEHOLDERS 58
1.5 LIMITATIONS 59
1.6 SUMMARY OF CHANGES 59
1.7 RECESSION IMPACT 60
2 RESEARCH METHODOLOGY 61
2.1 RESEARCH APPROACH 61
FIGURE 1 RESEARCH DESIGN 61
2.1.1 SECONDARY DATA 62
2.1.2 PRIMARY RESEARCH 63
FIGURE 2 SYNTHETIC BIOLOGY MARKET: PRIMARY RESPONDENTS 63
2.2 MARKET ESTIMATION METHODOLOGY 64
2.2.1 AVERAGE MARKET SIZE ESTIMATION (2021) 65
2.2.2 REVENUE MAPPING-BASED MARKET ESTIMATION 66
FIGURE 3 MARKET SIZE ESTIMATION: REVENUE-BASED ESTIMATION METHODOLOGY 66
2.3 DATA TRIANGULATION 67
FIGURE 4 DATA TRIANGULATION METHODOLOGY 67
2.4 GROWTH RATE ASSUMPTIONS 68
2.5 GROWTH FORECAST 68
FIGURE 5 GROWTH RATE ANALYSIS FOR SYNTHETIC BIOLOGY MARKET 68
2.6 RISK ASSESSMENT 68
2.7 INSIGHTS FROM PRIMARY EXPERTS 69
2.8 RECESSION IMPACT 69
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2027 69
3 EXECUTIVE SUMMARY 71
FIGURE 6 SYNTHETIC BIOLOGY MARKET, BY TOOL, 2022 VS. 2027 (USD MILLION) 71
FIGURE 7 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2022 VS. 2027 (USD MILLION) 72
FIGURE 8 SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2022 VS. 2027 (USD MILLION) 73
FIGURE 9 REGIONAL SNAPSHOT OF SYNTHETIC BIOLOGY MARKET 74
4 PREMIUM INSIGHTS 75
4.1 SYNTHETIC BIOLOGY MARKET OVERVIEW 75
FIGURE 10 DIVERSE APPLICATIONS OF SYNTHETIC BIOLOGY TO DRIVE MARKET 75
4.2 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION AND COUNTRY (2021) 76
FIGURE 11 US ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN SYNTHETIC BIOLOGY MARKET IN 2021 76
4.3 SYNTHETIC BIOLOGY MARKET SHARE, BY APPLICATION, 2021 77
FIGURE 12 MEDICAL APPLICATIONS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2021 77
4.4 SYNTHETIC BIOLOGY MARKET: REGIONAL GROWTH OPPORTUNITIES 78
FIGURE 13 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 78
5 MARKET OVERVIEW 79
5.1 INTRODUCTION 79
5.2 MARKET DYNAMICS 79
FIGURE 14 SYNTHETIC BIOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 79
TABLE 2 SYNTHETIC BIOLOGY MARKET: IMPACT ANALYSIS 80
5.2.1 DRIVERS 80
5.2.1.1 Diverse applications of synthetic biology 80
5.2.1.2 Increased funding for research in synthetic biology 82
5.2.1.3 Declining cost of DNA sequencing and synthesizing 83
FIGURE 15 REDUCTION IN COST PER RAW MEGABASE OF DNA SEQUENCING (USD), 2010–2020 83
5.2.1.4 Innovations in synthetic biology 83
5.2.2 RESTRAINTS 84
5.2.2.1 Biosafety, biosecurity, and ethical concerns 84
5.2.3 OPPORTUNITIES 85
5.2.3.1 Increasing demand for fuel alternatives 85
5.2.3.2 Growth in research on synthetic drugs and vaccines 86
TABLE 3 CLINICAL TRIALS UTILIZING ANTIGENS OR BIOLOGICAL MATERIALS IN VACCINES 86
5.2.3.3 Use of machine learning in research and development 87
5.2.4 CHALLENGES 87
5.2.4.1 Standardization of biological parts 87
5.3 TECHNOLOGY ANALYSIS 88
TABLE 4 COMPARISON OF MODERN GENE EDITING TOOLS 88
TABLE 5 MACHINE LEARNING METHODS CURRENTLY APPLIED IN METABOLIC MODELS OF INDUSTRIAL MICROORGANISMS 89
5.4 ECOSYSTEM ANALYSIS 90
FIGURE 16 ECOSYSTEM ANALYSIS: SYNTHETIC BIOLOGY MARKET 90
TABLE 6 SYNTHETIC BIOLOGY MARKET: ROLE IN ECOSYSTEM 90
5.5 PATENT ANALYSIS 92
5.6 PRICING ANALYSIS 93
TABLE 7 AVERAGE SELLING PRICE OF SYNTHETIC BIOLOGY PRODUCTS (2021) 93
TABLE 8 SELLING PRICE OF VARIOUS PRODUCTS/SERVICES, BY KEY PLAYER 93
5.7 PORTER’S FIVE FORCES ANALYSIS 94
TABLE 9 SYNTHETIC BIOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 94
5.7.1 THREAT OF NEW ENTRANTS 95
5.7.2 THREAT OF SUBSTITUTES 95
5.7.3 BARGAINING POWER OF SUPPLIERS 95
5.7.4 BARGAINING POWER OF BUYERS 95
5.7.5 INTENSITY OF COMPETITIVE RIVALRY 95
5.8 VALUE CHAIN ANALYSIS 96
FIGURE 17 VALUE CHAIN ANALYSIS OF SYNTHETIC BIOLOGY MARKET: MANUFACTURING AND ASSEMBLY PHASES ADD MAXIMUM VALUE 96
5.9 REGULATORY ANALYSIS 97
5.9.1 REGULATIONS FOR PRODUCTS DEVELOPED USING SYNTHETIC BIOLOGY TECHNIQUES 97
TABLE 10 REGULATIONS FOR PRODUCTS DEVELOPED USING SYNTHETIC BIOLOGY TECHNIQUES 98
5.9.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 11 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 98
TABLE 12 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99
TABLE 13 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 99
5.10 KEY CONFERENCES AND EVENTS IN 2022–2023 100
TABLE 14 SYNTHETIC BIOLOGY MARKET: DETAILED LIST OF CONFERENCES AND EVENTS 100
5.11 KEY STAKEHOLDERS AND BUYING CRITERIA 101
5.11.1 KEY STAKEHOLDERS IN BUYING PROCESS 101
FIGURE 18 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 101
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 101
5.11.2 BUYING CRITERIA 102
FIGURE 19 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 102
5.12 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 102
6 SYNTHETIC BIOLOGY MARKET, BY TOOL 103
6.1 INTRODUCTION 104
TABLE 16 SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 104
6.2 OLIGONUCLEOTIDES AND SYNTHETIC DNA 104
6.2.1 INCREASING DEMAND FOR SYNTHETIC DNA TO SUPPORT MARKET GROWTH 104
TABLE 17 SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES AND SYNTHETIC DNA, BY REGION, 2020–2027 (USD MILLION) 105
TABLE 18 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES AND SYNTHETIC DNA, BY COUNTRY, 2020–2027 (USD MILLION) 106
TABLE 19 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES AND SYNTHETIC DNA, BY COUNTRY, 2020–2027 (USD MILLION) 106
TABLE 20 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES AND SYNTHETIC DNA, BY COUNTRY, 2020–2027 (USD MILLION) 107
TABLE 21 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OLIGONUCLEOTIDES AND SYNTHETIC DNA, BY COUNTRY, 2020–2027 (USD MILLION) 107
6.3 ENZYMES 107
6.3.1 LAUNCH OF NOVEL ENZYMES TO PROPEL MARKET 107
TABLE 22 SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY REGION, 2020–2027 (USD MILLION) 108
TABLE 23 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION) 109
TABLE 24 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION) 109
TABLE 25 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION) 110
TABLE 26 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION) 110
6.4 CLONING TECHNOLOGY KITS 111
6.4.1 NEED FOR CREATION OF ARTIFICIAL DNA AND ASSEMBLY TO DRIVE MARKET 111
TABLE 27 SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY REGION, 2020–2027 (USD MILLION) 111
TABLE 28 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 29 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2020–2027 (USD MILLION) 112
TABLE 30 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2020–2027 (USD MILLION) 113
TABLE 31 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING TECHNOLOGY KITS, BY COUNTRY, 2020–2027 (USD MILLION) 113
6.5 SYNTHETIC CELLS 113
6.5.1 RISING DEMAND FOR SYNTHETIC CELLS TO SUPPORT MARKET GROWTH 113
TABLE 32 SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY REGION, 2020–2027 (USD MILLION) 114
TABLE 33 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2020–2027 (USD MILLION) 115
TABLE 34 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2020–2027 (USD MILLION) 115
TABLE 35 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2020–2027 (USD MILLION) 116
TABLE 36 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SYNTHETIC CELLS, BY COUNTRY, 2020–2027 (USD MILLION) 116
 
6.6 CHASSIS ORGANISMS 117
6.6.1 INCREASING DEMAND FOR FOSSIL FUELS TO PROPEL MARKET 117
TABLE 37 SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY REGION, 2020–2027 (USD MILLION) 117
TABLE 38 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2020–2027 (USD MILLION) 118
TABLE 39 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2020–2027 (USD MILLION) 118
TABLE 40 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2020–2027 (USD MILLION) 119
TABLE 41 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CHASSIS ORGANISMS, BY COUNTRY, 2020–2027 (USD MILLION) 119
6.7 XENO NUCLEIC ACIDS 120
6.7.1 GROWING DEMAND FOR BREAKTHROUGH MEDICINES TO SUPPORT MARKET GROWTH 120
TABLE 42 SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY REGION, 2020–2027 (USD MILLION) 120
TABLE 43 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 44 EUROPE: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 45 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2020–2027 (USD MILLION) 122
TABLE 46 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR XENO NUCLEIC ACIDS, BY COUNTRY, 2020–2027 (USD MILLION) 122
7 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY 123
7.1 INTRODUCTION 124
TABLE 47 SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 124
7.2 GENE SYNTHESIS 124
7.2.1 GENE SYNTHESIS TO DOMINATE MARKET DURING FORECAST PERIOD 124
TABLE 48 SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY REGION, 2020–2027 (USD MILLION) 126
TABLE 49 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION) 126
TABLE 50 EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION) 127
TABLE 51 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION) 127
TABLE 52 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENE SYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION) 128
7.3 GENOME ENGINEERING 128
7.3.1 INCREASING DEMAND FOR SYNTHETIC DNA AND GENES TO DRIVE MARKET 128
TABLE 53 SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY REGION, 2020–2027 (USD MILLION) 129
TABLE 54 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2020–2027 (USD MILLION) 129
TABLE 55 EUROPE: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2020–2027 (USD MILLION) 130
TABLE 56 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2020–2027 (USD MILLION) 130
TABLE 57 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR GENOME ENGINEERING, BY COUNTRY, 2020–2027 (USD MILLION) 131
7.4 SEQUENCING 131
7.4.1 NGS TECHNOLOGY REQUISITE FOR BIOLOGICAL RESEARCH 131
TABLE 58 SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY REGION, 2020–2027 (USD MILLION) 132
TABLE 59 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2020–2027 (USD MILLION) 132
TABLE 60 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2020–2027 (USD MILLION) 133
TABLE 61 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2020–2027 (USD MILLION) 133
TABLE 62 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SEQUENCING, BY COUNTRY, 2020–2027 (USD MILLION) 134
7.5 BIOINFORMATICS 134
7.5.1 RISING NEED FOR DATA MANAGEMENT AND CURATION TO DRIVE ADOPTION OF BIOINFORMATICS TECHNOLOGIES 134
TABLE 63 SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY REGION, 2020–2027 (USD MILLION) 135
TABLE 64 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2020–2027 (USD MILLION) 135
TABLE 65 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 66 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2020–2027 (USD MILLION) 136
TABLE 67 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOINFORMATICS, BY COUNTRY, 2020–2027 (USD MILLION) 137
7.6 CLONING 137
7.6.1 CLONING AIDS IN BUILDING NEW GENETIC MODULES/PATHWAYS, ENABLING RAPID ADVANCES IN RESEARCH ACROSS INDUSTRIES 137
TABLE 68 SYNTHETIC BIOLOGY MARKET FOR CLONING, BY REGION, 2020–2027 (USD MILLION) 138
TABLE 69 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2020–2027 (USD MILLION) 138
TABLE 70 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2020–2027 (USD MILLION) 139
TABLE 71 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2020–2027 (USD MILLION) 139
TABLE 72 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CLONING, BY COUNTRY, 2020–2027 (USD MILLION) 140
7.7 SITE-DIRECTED MUTAGENESIS 140
7.7.1 WIDE APPLICATIONS IN GENETIC ENGINEERING, DNA ASSEMBLY, AND CLONING TECHNOLOGIES TO DRIVE MARKET 140
TABLE 73 SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY REGION, 2020–2027 (USD MILLION) 141
TABLE 74 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2020–2027 (USD MILLION) 141
TABLE 75 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2020–2027 (USD MILLION) 142
TABLE 76 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2020–2027 (USD MILLION) 142
TABLE 77 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SITE-DIRECTED MUTAGENESIS, BY COUNTRY, 2020–2027 (USD MILLION) 143
7.8 MEASUREMENT AND MODELING 143
7.8.1 CELL-FREE SYNTHETIC BIOLOGY EMERGING AS POWERFUL TECHNOLOGY 143
TABLE 78 SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT AND MODELING, BY REGION, 2020–2027 (USD MILLION) 144
TABLE 79 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT AND MODELING, BY COUNTRY, 2020–2027 (USD MILLION) 144
TABLE 80 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT AND MODELING, BY COUNTRY, 2020–2027 (USD MILLION) 145
TABLE 81 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT AND MODELING, BY COUNTRY, 2020–2027 (USD MILLION) 145
TABLE 82 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEASUREMENT AND MODELING, BY COUNTRY, 2020–2027 (USD MILLION) 146
7.9 MICROFLUIDICS 146
7.9.1 DROPLET MICROFLUIDICS GAINING WIDE RECOGNITION IN FIELD OF SYNTHETIC BIOLOGY 146
TABLE 83 SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY REGION, 2020–2027 (USD MILLION) 147
TABLE 84 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2020–2027 (USD MILLION) 147
TABLE 85 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2020–2027 (USD MILLION) 148
TABLE 86 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2020–2027 (USD MILLION) 148
TABLE 87 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MICROFLUIDICS, BY COUNTRY, 2020–2027 (USD MILLION) 149
7.10 NANOTECHNOLOGY 149
7.10.1 CONVERGENCE BETWEEN SYNTHETIC BIOLOGY AND NANOTECHNOLOGY AIDS IN BUILDING COMPLEX BODIES 149
TABLE 88 SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY REGION, 2020–2027 (USD MILLION) 150
TABLE 89 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 150
TABLE 90 EUROPE: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 151
TABLE 91 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 151
TABLE 92 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR NANOTECHNOLOGY, BY COUNTRY, 2020–2027 (USD MILLION) 152
 
8 SYNTHETIC BIOLOGY MARKET, BY APPLICATION 153
8.1 INTRODUCTION 154
TABLE 93 SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 154
8.2 MEDICAL APPLICATIONS 154
TABLE 94 SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 155
TABLE 95 SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 155
TABLE 96 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 156
TABLE 97 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2020–2027(USD MILLION) 156
TABLE 98 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 157
TABLE 99 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 157
8.2.1 PHARMACEUTICALS 157
8.2.1.1 Largest synthetic biology market for medical applications 157
TABLE 100 SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY REGION, 2020–2027 (USD MILLION) 158
TABLE 101 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2020–2027 (USD MILLION) 159
TABLE 102 EUROPE: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2020–2027 (USD MILLION) 159
TABLE 103 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2020–2027 (USD MILLION) 160
TABLE 104 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PHARMACEUTICALS, BY COUNTRY, 2020–2027 (USD MILLION) 160
8.2.2 DRUG DISCOVERY AND THERAPEUTICS 160
TABLE 105 SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 161
TABLE 106 SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY REGION, 2020–2027 (USD MILLION) 161
TABLE 107 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY, 2020–2027 (USD MILLION) 162
TABLE 108 EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY, 2020–2027 (USD MILLION) 162
TABLE 109 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY, 2020–2027 (USD MILLION) 163
TABLE 110 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY COUNTRY, 2020–2027 (USD MILLION) 163
8.2.2.1 Cancer detection and diagnostics 163
8.2.2.1.1 Increasing investments in cancer research to support market 163
TABLE 111 SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION AND DIAGNOSTICS, BY REGION, 2020–2027 (USD MILLION) 164
TABLE 112 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION AND DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 165
TABLE 113 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION AND DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 165
TABLE 114 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION AND DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 166
TABLE 115 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CANCER DETECTION AND DIAGNOSTICS, BY COUNTRY, 2020–2027 (USD MILLION) 166
8.2.2.2 Other drug discovery and therapeutic applications 166
TABLE 116 SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 167
TABLE 117 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 167
TABLE 118 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 168
TABLE 119 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 168
TABLE 120 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER DRUG DISCOVERY AND THERAPEUTIC APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 169
8.2.3 ARTIFICIAL TISSUE AND TISSUE REGENERATION 169
TABLE 121 SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 170
TABLE 122 SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY REGION, 2020–2027 (USD MILLION) 170
TABLE 123 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY COUNTRY, 2020–2027 (USD MILLION) 171
TABLE 124 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY COUNTRY, 2020–2027 (USD MILLION) 171
TABLE 125 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY COUNTRY, 2020–2027 (USD MILLION) 172
TABLE 126 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY COUNTRY, 2020–2027 (USD MILLION) 172
8.2.3.1 Biosynthesis 172
8.2.3.1.1 Largest market due to increasing need to create artificial genomes 172
TABLE 127 SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY REGION, 2020–2027 (USD MILLION) 173
TABLE 128 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION) 173
TABLE 129 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION) 174
TABLE 130 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION) 174
TABLE 131 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOSYNTHESIS, BY COUNTRY, 2020–2027 (USD MILLION) 175
8.2.3.2 Stem cell regulation 175
8.2.3.2.1 Increased use of synthetic biology in stem cell regeneration and reprogramming somatic cells to drive market 175
 
TABLE 132 SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY REGION, 2020–2027 (USD MILLION) 176
TABLE 133 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2020–2027 (USD MILLION) 176
TABLE 134 EUROPE: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2020–2027 (USD MILLION) 177
TABLE 135 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2020–2027 (USD MILLION) 177
TABLE 136 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR STEM CELL REGULATION, BY COUNTRY, 2020–2027 (USD MILLION) 178
8.2.3.3 Other artificial tissue and tissue regeneration applications 178
TABLE 137 SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE AND TISSUE REGENERATION APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 179
TABLE 138 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE AND TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 179
TABLE 139 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE AND TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 180
TABLE 140 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE AND TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 180
TABLE 141 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER ARTIFICIAL TISSUE AND TISSUE REGENERATION APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 181
8.3 INDUSTRIAL APPLICATIONS 181
TABLE 142 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 182
TABLE 143 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 182
TABLE 144 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 183
TABLE 145 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 183
TABLE 146 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 184
TABLE 147 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 184
8.3.1 BIOFUEL AND RENEWABLE ENERGY 184
8.3.1.1 Advantages of using genetically engineered organisms for synthetic production of biofuels to support market 184
TABLE 148 SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY REGION, 2020–2027 (USD MILLION) 185
TABLE 149 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY, 2020–2027 (USD MILLION) 186
TABLE 150 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY, 2020–2027 (USD MILLION) 186
TABLE 151 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY, 2020–2027 (USD MILLION) 187
TABLE 152 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOFUEL AND RENEWABLE ENERGY, BY COUNTRY, 2020–2027 (USD MILLION) 187
8.3.2 INDUSTRIAL ENZYMES 187
TABLE 153 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 188
TABLE 154 SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY REGION, 2020–2027 (USD MILLION) 189
TABLE 155 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION) 189
TABLE 156 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION) 190
TABLE 157 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION) 190
TABLE 158 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY COUNTRY, 2020–2027 (USD MILLION) 191
8.3.2.1 Textile industry 191
8.3.2.1.1 Synthetic biology to replace traditional raw materials in textile industry 191
TABLE 159 SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY REGION, 2020–2027 (USD MILLION) 192
TABLE 160 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION) 192
TABLE 161 EUROPE: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION) 193
TABLE 162 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION) 193
TABLE 163 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR TEXTILE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION) 194
8.3.2.2 Paper industry 194
8.3.2.2.1 Increasing use of enzymes in pulp and paper industry to favor market growth 194
TABLE 164 SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY REGION, 2020–2027 (USD MILLION) 195
TABLE 165 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION) 195
TABLE 166 EUROPE: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION) 196
TABLE 167 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION) 196
TABLE 168 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR PAPER INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION) 197
8.3.2.3 Consumer care industry 197
TABLE 169 SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 197
TABLE 170 SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY REGION, 2020–2027 (USD MILLION) 198
TABLE 171 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION) 198
TABLE 172 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION) 199
TABLE 173 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION) 199
TABLE 174 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY COUNTRY, 2020–2027 (USD MILLION) 200
8.3.2.3.1 Cosmetics 200
8.3.2.3.1.1 Increased use of synthetic biology techniques for development of skincare and cosmetics to propel market 200
TABLE 175 SYNTHETIC BIOLOGY MARKET FOR SKINCARE AND COSMETICS, BY REGION, 2020–2027 (USD MILLION) 201
TABLE 176 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKINCARE AND COSMETICS, BY COUNTRY, 2020–2027 (USD MILLION) 201
TABLE 177 EUROPE: SYNTHETIC BIOLOGY MARKET FOR SKINCARE AND COSMETICS, BY COUNTRY, 2020–2027 (USD MILLION) 202
TABLE 178 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR SKINCARE AND COSMETICS, BY COUNTRY, 2020–2027 (USD MILLION) 202
TABLE 179 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR SKINCARE AND COSMETICS, BY COUNTRY, 2020–2027 (USD MILLION) 203
8.3.2.3.2 Other consumer care products 203
TABLE 180 SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY REGION, 2020–2027 (USD MILLION) 204
TABLE 181 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 204
TABLE 182 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 205
TABLE 183 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 205
TABLE 184 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER CONSUMER CARE PRODUCTS, BY COUNTRY, 2020–2027 (USD MILLION) 206
8.3.2.4 Other industries 206
TABLE 185 SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY REGION, 2020–2027 (USD MILLION) 207
TABLE 186 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2020–2027 (USD MILLION) 207
TABLE 187 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2020–2027 (USD MILLION) 208
TABLE 188 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2020–2027 (USD MILLION) 208
TABLE 189 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER INDUSTRIES, BY COUNTRY, 2020–2027 (USD MILLION) 209
8.3.3 BIOMATERIALS AND GREEN CHEMICALS 209
8.3.3.1 Use of synthetic biology for preparing silk-based proteins to support market 209
TABLE 190 SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY REGION, 2020–2027 (USD MILLION) 210
TABLE 191 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION) 210
TABLE 192 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION) 211
TABLE 193 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION) 211
TABLE 194 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOMATERIALS AND GREEN CHEMICALS, BY COUNTRY, 2020–2027 (USD MILLION) 212
8.4 FOOD AND AGRICULTURAL APPLICATIONS 212
TABLE 195 SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 213
TABLE 196 SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 213
TABLE 197 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 214
TABLE 198 EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 214
TABLE 199 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 215
TABLE 200 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 215
8.4.1 FLAVORS AND FRAGRANCES 215
8.4.1.1 Manufactured using engineered microbes 215
TABLE 201 SYNTHETIC BIOLOGY MARKET FOR FLAVORS AND FRAGRANCES, BY REGION, 2020–2027 (USD MILLION) 216
TABLE 202 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FLAVORS AND FRAGRANCES, BY COUNTRY, 2020–2027 (USD MILLION) 216
TABLE 203 EUROPE: SYNTHETIC BIOLOGY MARKET FOR FLAVORS AND FRAGRANCES, BY COUNTRY, 2020–2027 (USD MILLION) 217
TABLE 204 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FLAVORS AND FRAGRANCES, BY COUNTRY, 2020–2027 (USD MILLION) 217
TABLE 205 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FLAVORS AND FRAGRANCES, BY COUNTRY, 2020–2027 (USD MILLION) 218
8.4.2 OTHER FOOD AND AGRICULTURAL APPLICATIONS 218
TABLE 206 SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD AND AGRICULTURAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 219
TABLE 207 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 219
TABLE 208 EUROPE: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 220
TABLE 209 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 220
TABLE 210 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR OTHER FOOD AND AGRICULTURAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 221

8.5 ENVIRONMENTAL APPLICATIONS 221
TABLE 211 SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 222
TABLE 212 SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2020–2027 (USD MILLION) 222
TABLE 213 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 223
TABLE 214 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 223
TABLE 215 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 224
TABLE 216 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY COUNTRY, 2020–2027 (USD MILLION) 224
8.5.1 BIOREMEDIATION 224
8.5.1.1 Bioremediation helps in cleaning oil spills, preventing chemical pollution, and plugging nuclear leakages 224
TABLE 217 SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY REGION, 2020–2027 (USD MILLION) 225
TABLE 218 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY, 2020–2027 (USD MILLION) 225
TABLE 219 EUROPE: SYNTHETIC BIOLOGY MARKET FOR BIOREMEDIATION, BY COUNTRY
9 SYNTHETIC BIOLOGY MARKET, BY REGION 231
9.1 INTRODUCTION 232
TABLE 227 SYNTHETIC BIOLOGY MARKET, BY REGION, 2020–2027 (USD MILLION) 232
9.2 NORTH AMERICA 233
FIGURE 20 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET SNAPSHOT 234
TABLE 228 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 235
TABLE 229 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 235
TABLE 230 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 236
TABLE 231 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 236
TABLE 232 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 237
TABLE 233 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 237
TABLE 234 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 238
TABLE 235 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 238
TABLE 236 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 239
TABLE 237 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 239
TABLE 238 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 240
TABLE 239 NORTH AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 240
9.2.1 US 240
9.2.1.1 US accounts for highest number of studies carried out on synthetic biology globally 240
TABLE 240 US: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 242
TABLE 241 US: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 242
TABLE 242 US: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 243
TABLE 243 US: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 243
TABLE 244 US: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 244
TABLE 245 US: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 244
TABLE 246 US: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 245
TABLE 247 US: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 245
TABLE 248 US: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 246
TABLE 249 US: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 246
TABLE 250 US: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 246
9.2.2 CANADA 247
9.2.2.1 Strong research infrastructure and availability of funding to support market 247
TABLE 251 CANADA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 248
TABLE 252 CANADA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 248
TABLE 253 CANADA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 249
TABLE 254 CANADA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 249
TABLE 255 CANADA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 250
TABLE 256 CANADA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 250
TABLE 257 CANADA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 251
TABLE 258 CANADA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 251
TABLE 259 CANADA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 252
TABLE 260 CANADA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 252
TABLE 261 CANADA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 252
9.2.3 RECESSION IMPACT 253
9.3 EUROPE 253
TABLE 262 EUROPE: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 254
TABLE 263 EUROPE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 254
TABLE 264 EUROPE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 255
TABLE 265 EUROPE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 255
TABLE 266 EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 256
TABLE 267 EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 256
TABLE 268 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 257
TABLE 269 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 257
TABLE 270 EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 258
TABLE 271 EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 258
TABLE 272 EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 259
TABLE 273 EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 259
9.3.1 GERMANY 259
9.3.1.1 Rapidly growing pharmaceutical market to drive market 259
TABLE 274 GERMANY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 260
TABLE 275 GERMANY: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 261
TABLE 276 GERMANY: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 261
TABLE 277 GERMANY: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 262
TABLE 278 GERMANY: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 262
TABLE 279 GERMANY: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 263
TABLE 280 GERMANY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 263
TABLE 281 GERMANY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 264
TABLE 282 GERMANY: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 264
TABLE 283 GERMANY: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 265
TABLE 284 GERMANY: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 265
9.3.2 UK 265
9.3.2.1 Increasing R&D expenditure to favor market 265
TABLE 285 UK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 266
TABLE 286 UK: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 267
TABLE 287 UK: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 267
TABLE 288 UK: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 268
TABLE 289 UK: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 268
TABLE 290 UK: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 269
TABLE 291 UK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 269
TABLE 292 UK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 270
TABLE 293 UK: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 270
TABLE 294 UK: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 271
TABLE 295 UK: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 271
9.3.3 FRANCE 271
9.3.3.1 Availability of funds from government and private organizations for domestic drug development to support market 271
TABLE 296 FRANCE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 272
TABLE 297 FRANCE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 273
TABLE 298 FRANCE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 273
TABLE 299 FRANCE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 274
TABLE 300 FRANCE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 274
TABLE 301 FRANCE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 275
TABLE 302 FRANCE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 275
TABLE 303 FRANCE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 276
TABLE 304 FRANCE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 276
TABLE 305 FRANCE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 277
TABLE 306 FRANCE: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 277
9.3.4 SWITZERLAND 278
9.3.4.1 Well-established pharmaceutical and biotechnology industry to favor market 278
TABLE 307 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 278
TABLE 308 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 279
TABLE 309 SWITZERLAND: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 279
TABLE 310 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 280
TABLE 311 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 280
TABLE 312 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 281
TABLE 313 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 281
TABLE 314 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 282
TABLE 315 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 282
TABLE 316 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 283
TABLE 317 SWITZERLAND: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 283
9.3.5 DENMARK 284
9.3.5.1 Third-largest commercial drug development pipeline in Europe to drive market 284
TABLE 318 DENMARK: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 284
TABLE 319 DENMARK: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 285
TABLE 320 DENMARK: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 285
TABLE 321 DENMARK: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 286
TABLE 322 DENMARK: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 286
TABLE 323 DENMARK: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 287
TABLE 324 DENMARK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 287
TABLE 325 DENMARK: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 288
TABLE 326 DENMARK: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 288
TABLE 327 DENMARK: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 289
TABLE 328 DENMARK: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 289
9.3.6 ITALY 290
9.3.6.1 Increasing life science R&D, funded by both public and private organizations, to drive market 290
TABLE 329 ITALY: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 290
TABLE 330 ITALY: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 291
TABLE 331 ITALY: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 291
TABLE 332 ITALY: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 292
TABLE 333 ITALY: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 292
TABLE 334 ITALY: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 293
TABLE 335 ITALY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 293
TABLE 336 ITALY: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 294
TABLE 337 ITALY: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 294
TABLE 338 ITALY: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 294
TABLE 339 ITALY: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 295
9.3.7 SPAIN 295
9.3.7.1 Well-established network of research centers, universities, and hospitals to support market 295
TABLE 340 SPAIN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 296
TABLE 341 SPAIN: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 296
TABLE 342 SPAIN: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 297
TABLE 343 SPAIN: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 297
TABLE 344 SPAIN: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 298
TABLE 345 SPAIN: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 298
TABLE 346 SPAIN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 299
TABLE 347 SPAIN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 299
TABLE 348 SPAIN: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 300
TABLE 349 SPAIN: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 300
TABLE 350 SPAIN: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 300
9.3.8 REST OF EUROPE 301
TABLE 351 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 302
TABLE 352 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 302
TABLE 353 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 303
TABLE 354 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 303
TABLE 355 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 304
TABLE 356 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 304
TABLE 357 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 305
TABLE 358 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 305
TABLE 359 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 306
TABLE 360 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 306
TABLE 361 REST OF EUROPE: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 306
9.3.9 RECESSION IMPACT 307
9.4 ASIA PACIFIC 307
FIGURE 21 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET SNAPSHOT 308
TABLE 362 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 309
TABLE 363 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 309
TABLE 364 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 310
TABLE 365 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 310
TABLE 366 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 311
TABLE 367 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 311
TABLE 368 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 312
TABLE 369 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 312
TABLE 370 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 313
TABLE 371 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 313
TABLE 372 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 314
TABLE 373 ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 314
9.4.1 CHINA 314
9.4.1.1 Growing R&D to enhance technological capabilities to favor market 314
TABLE 374 CHINA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 316
TABLE 375 CHINA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 316
TABLE 376 CHINA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 317
TABLE 377 CHINA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 317
TABLE 378 CHINA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 318
TABLE 379 CHINA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 318
TABLE 380 CHINA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 319
TABLE 381 CHINA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 319
TABLE 382 CHINA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 320
TABLE 383 CHINA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 320
TABLE 384 CHINA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 320
9.4.2 JAPAN 321
9.4.2.1 Large number of research initiatives for development of precision medicine to support market 321
TABLE 385 JAPAN: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 322
TABLE 386 JAPAN: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 322
TABLE 387 JAPAN: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 323
TABLE 388 JAPAN: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 323
TABLE 389 JAPAN: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 324
TABLE 390 JAPAN: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 324
TABLE 391 JAPAN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 325
TABLE 392 JAPAN: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 325
TABLE 393 JAPAN: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 326
TABLE 394 JAPAN: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 326
TABLE 395 JAPAN: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 326
9.4.3 AUSTRALIA 327
9.4.3.1 Increasing focus of healthcare system on precision medicine to offer significant growth opportunities 327
TABLE 396 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 327
TABLE 397 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 328
TABLE 398 AUSTRALIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 328
TABLE 399 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 329
TABLE 400 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 329
TABLE 401 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 330
TABLE 402 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 330
TABLE 403 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 331
TABLE 404 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 331
TABLE 405 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 332
TABLE 406 AUSTRALIA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 332
9.4.4 INDIA 332
9.4.4.1 Increasing pharma R&D activities and government funding for biotechnology industry to support market 332
TABLE 407 INDIA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 333
TABLE 408 INDIA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 334
TABLE 409 INDIA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 334
TABLE 410 INDIA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 335
TABLE 411 INDIA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 335
TABLE 412 INDIA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 336
TABLE 413 INDIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 336
TABLE 414 INDIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 337
TABLE 415 INDIA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 337
TABLE 416 INDIA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 338
TABLE 417 INDIA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 338
9.4.5 REST OF ASIA PACIFIC 338
TABLE 418 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 340
TABLE 419 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 340
TABLE 420 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 341
TABLE 421 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 341
TABLE 422 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 342
TABLE 423 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 342
TABLE 424 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 343
TABLE 425 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 343
TABLE 426 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 344
TABLE 427 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 344
TABLE 428 REST OF ASIA PACIFIC: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 344
9.4.6 RECESSION IMPACT 345
9.5 LATIN AMERICA 345
TABLE 429 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 346
TABLE 430 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 346
TABLE 431 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 347
TABLE 432 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 347
TABLE 433 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 348
TABLE 434 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 348
TABLE 435 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 349
TABLE 436 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 349
TABLE 437 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 350
TABLE 438 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 350
TABLE 439 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 351
TABLE 440 LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 351
9.5.1 BRAZIL 351
9.5.1.1 Growing pharmaceutical industry to drive market 351
TABLE 441 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 352
TABLE 442 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 352
TABLE 443 BRAZIL: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 353
TABLE 444 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 353
TABLE 445 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 354
TABLE 446 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 354
TABLE 447 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 355
TABLE 448 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 355
TABLE 449 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 356
TABLE 450 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 356
TABLE 451 BRAZIL: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 356
9.5.2 MEXICO 357
9.5.2.1 Increasing support for biotechnology infrastructure development to drive market 357
TABLE 452 MEXICO: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 357
TABLE 453 MEXICO: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 358
TABLE 454 MEXICO: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 358
TABLE 455 MEXICO: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 359
TABLE 456 MEXICO: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 359
TABLE 457 MEXICO: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 360
TABLE 458 MEXICO: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 360
TABLE 459 MEXICO: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 361
TABLE 460 MEXICO: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 361
TABLE 461 MEXICO: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 362
TABLE 462 MEXICO: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 362
9.5.3 REST OF LATIN AMERICA 362
TABLE 463 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 363
TABLE 464 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY TECHNO LOGY, 2020–2027 (USD MILLION) 363
TABLE 465 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 364
TABLE 466 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 364
TABLE 467 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 365
TABLE 468 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 365
TABLE 469 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 366
TABLE 470 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 366
TABLE 471 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 367
TABLE 472 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 367
TABLE 473 REST OF LATIN AMERICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 367
9.5.4 RECESSION IMPACT 368
9.6 MIDDLE EAST AND AFRICA 368
TABLE 474 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET, BY TOOL, 2020–2027 (USD MILLION) 369
TABLE 475 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET, BY TECHNOLOGY, 2020–2027 (USD MILLION) 369
TABLE 476 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET, BY APPLICATION, 2020–2027 (USD MILLION) 370
TABLE 477 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET FOR MEDICAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 370
TABLE 478 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET FOR DRUG DISCOVERY AND THERAPEUTICS, BY TYPE, 2020–2027 (USD MILLION) 371
TABLE 479 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET FOR ARTIFICIAL TISSUE AND TISSUE REGENERATION, BY TYPE, 2020–2027 (USD MILLION) 371
TABLE 480 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 372
TABLE 481 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2020–2027 (USD MILLION) 372
TABLE 482 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET FOR CONSUMER CARE INDUSTRY, BY TYPE, 2020–2027 (USD MILLION) 373
TABLE 483 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET FOR ENVIRONMENTAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 373
TABLE 484 MIDDLE EAST & AFRICA: SYNTHETIC BIOLOGY MARKET FOR FOOD AND AGRICULTURAL APPLICATIONS, BY TYPE, 2020–2027 (USD MILLION) 373
9.6.1 RECESSION IMPACT 374

10 COMPETITIVE LANDSCAPE 375
10.1 OVERVIEW 375
10.2 STRATEGIES ADOPTED BY KEY PLAYERS 375
FIGURE 22 STRATEGIES ADOPTED BY KEY PLAYERS IN SYNTHETIC BIOLOGY MARKET, 2019–2022 376
10.3 REVENUE SHARE ANALYSIS 377
10.4 MARKET SHARE ANALYSIS 378
FIGURE 24 SYNTHETIC BIOLOGY MARKET SHARE ANALYSIS, BY KEY PLAYER, 2021 378
TABLE 485 SYNTHETIC BIOLOGY MARKET: DEGREE OF COMPETITION 379
10.5 COMPANY EVALUATION QUADRANT 380
10.5.1 STARS 380
10.5.2 EMERGING LEADERS 380
10.5.3 PERVASIVE PLAYERS 380
10.5.4 PARTICIPANTS 380
FIGURE 25 SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION QUADRANT, 2021 381
10.6 COMPANY EVALUATION QUADRANT: STARTUPS/SMES 382
10.6.1 PROGRESSIVE COMPANIES 382
10.6.2 STARTING BLOCKS 382
10.6.3 RESPONSIVE COMPANIES 382
10.6.4 DYNAMIC COMPANIES 382
FIGURE 26 SYNTHETIC BIOLOGY MARKET: COMPANY EVALUATION QUADRANT FOR STARTUPS/SMES, 2021 383
10.7 COMPANY FOOTPRINT ANALYSIS 384
10.8 PRODUCT FOOTPRINT ANALYSIS 385
TABLE 486 PRODUCT FOOTPRINT ANALYSIS OF COMPANIES IN SYNTHETIC BIOLOGY MARKET (2022) 385
10.9 REGIONAL FOOTPRINT ANALYSIS 386
TABLE 487 REGIONAL FOOTPRINT ANALYSIS OF COMPANIES IN SYNTHETIC BIOLOGY MARKET (2022) 386
10.10 COMPETITIVE SCENARIO 387
TABLE 488 SYNTHETIC BIOLOGY MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2019–DECEMBER 2022 387
TABLE 489 SYNTHETIC BIOLOGY MARKET: DEALS, JANUARY 2019–DECEMBER 2022 388
TABLE 490 SYNTHETIC BIOLOGY MARKET: OTHER DEVELOPMENTS, JANUARY 2019–DECEMBER 2022 389
11 COMPANY PROFILES 390
11.1 KEY MARKET PLAYERS 390
Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 THERMO FISHER SCIENTIFIC INC. 390
TABLE 491 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW 390
FIGURE 27 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2021) 391
11.1.2 MERCK KGAA 395
TABLE 492 MERCK KGAA: BUSINESS OVERVIEW 395
FIGURE 28 MERCK KGAA: COMPANY SNAPSHOT (2021) 396
11.1.3 NOVOZYMES (A NOVO HOLDINGS A/S COMPANY) 400
TABLE 493 NOVOZYMES: BUSINESS OVERVIEW 400
FIGURE 29 NOVOZYMES: COMPANY SNAPSHOT (2021) 401
11.1.4 EUROFINS SCIENTIFIC 405
TABLE 494 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW 405
FIGURE 30 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2021) 406
11.1.5 AGILENT TECHNOLOGIES 408
TABLE 495 AGILENT TECHNOLOGIES: BUSINESS OVERVIEW 408
FIGURE 31 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT (2021) 409
11.1.6 AMYRIS 412
TABLE 496 AMYRIS: BUSINESS OVERVIEW 412
FIGURE 32 AMYRIS: COMPANY SNAPSHOT (2021) 413
11.1.7 CODEXIS, INC. 416
TABLE 497 CODEXIS, INC.: BUSINESS OVERVIEW 416
FIGURE 33 CODEXIS, INC.: COMPANY SNAPSHOT (2021) 416
11.1.8 TWIST BIOSCIENCE 420
TABLE 498 TWIST BIOSCIENCE: BUSINESS OVERVIEW 420
FIGURE 34 TWIST BIOSCIENCE: COMPANY SNAPSHOT (2021) 421
11.1.9 GENSCRIPT 426
TABLE 499 GENSCRIPT: BUSINESS OVERVIEW 426
FIGURE 35 GENSCRIPT: COMPANY SNAPSHOT (2021) 427
11.1.10 PRECIGEN 429
TABLE 500 PRECIGEN: BUSINESS OVERVIEW 429
FIGURE 36 PRECIGEN: COMPANY SNAPSHOT (2021) 429
11.1.11 GINKGO BIOWORKS 431
TABLE 501 GINKGO BIOWORKS: BUSINESS OVERVIEW 431
FIGURE 37 GINKGO BIOWORKS: COMPANY SNAPSHOT (2021) 431
11.1.12 VIRIDOS (FORMERLY KNOWN AS SYNTHETIC GENOMICS) 434
TABLE 502 VIRIDOS (SYNTHETIC GENOMICS): BUSINESS OVERVIEW 434
11.1.13 SYNTHEGO 436
TABLE 503 SYNTHEGO: BUSINESS OVERVIEW 436
11.1.14 CREATIVE ENZYMES 438
TABLE 504 CREATIVE ENZYMES: BUSINESS OVERVIEW 438
11.1.15 CYRUS BIOTECHNOLOGY 440
TABLE 505 CYRUS BIOTECHNOLOGY: BUSINESS OVERVIEW 440
11.2 OTHER PLAYERS 442
11.2.1 ATUM 442
11.2.2 TESELAGEN 443
11.2.3 ARZEDA 443
11.2.4 INTEGRATED DNA TECHNOLOGIES 444
11.2.5 NEW ENGLAND BIOLABS 445
11.2.6 ELEVATEBIO 446
11.2.7 ZENFOLD (IOSYNTH) 447
11.2.8 SYNBIO TECHNOLOGIES 448
11.2.9 INSCRIPTA, INC. 449
11.2.10 CRISPR THERAPEUTICS 449
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 450
12.1 DISCUSSION GUIDE 450
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 457
12.3 CUSTOMIZATION OPTIONS 459
12.4 RELATED REPORTS 459
12.5 AUTHOR DETAILS 460

❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の合成生物学市場（～2027）：ツール別（オリゴヌクレオチド、酵素、合成細胞）、技術別、用途別(Synthetic Biology Market by Tools (Oligonucleotides, Enzymes, Synthetic Cells), Technology (Genome Engineering, Bioinformatics), Applications (Tissue Regeneration, Biofuel, Food, Agriculture, Consumer Care, Environmental)- Global Forecast to 2027)]についてメールでお問い合わせはこちらでお願いします。
グローバルリサーチ調査資料のイメージグローバルリサーチ調査資料のイメージ
◆関連リサーチレポート◆
  • 世界の遺伝子治療市場（～2028年）：種類別（遺伝子サイレンシング、遺伝子増強）、ベクター別（ウイルス性（レトロウイルス、AAV）、非ウイルス性（オリゴヌクレオチド））、治療領域別（神経科、腫瘍科）、デリバリー方法別（In-vivo、Ex-vivo）、RoA別（静脈内）、地域別
  • 移植のグローバル市場（～2027）：保存液、組織製品、免疫抑制薬、その他
  • ヒト化マウス＆ラットモデルの世界市場予測（～2027）：種類別、用途別、エンドユーザー別、地域別
  • 世界の生命科学分析市場（～2027）：種類別（予測的、記述的、プリスクリプティブ）、用途別、コンポーネント別、展開別、エンドユーザー別
  • 組織工学のグローバル市場予測（～2028）：スキャフォールド、組織移植片

    • ◆H&Iグローバルリサーチのお客様（例）◆